US purchases world stocks of Remdesivir—why the rest of the world should be glad to be at the back of the queue
The remdesivir story may actually be good news for the rest of the world, argues James M Brophy […]
The remdesivir story may actually be good news for the rest of the world, argues James M Brophy […]
Antiracist language is one way to explicitly consider ethnicity and racism within our institutions, both during the pandemic and beyond […]
Delays in sharing rotas is a long standing issue, but one that risks forcing doctors out of the profession, writes Rammina Yassaie […]
A crisis on the scale of the covid-19 pandemic requires a national response. But in a country as large and diverse as the United Kingdom, where the impact of the […]
Tackling racism in medicine can only come about with honest conversations. Christine Ekechi suggests we can start that journey in three ways […]
Alex Nowbar reviews the latest research from the top medical journals. […]
The covid-19 pandemic has drawn our collective attention to the vulnerabilities of healthcare workers (HCWs). Currently, these vulnerabilities are largely couched in proximal terms of long working hours and shortages […]
The demise of most medical journals and the transformation of the remaining rump has been predicted for years, not least in my book The Trouble With Medical Journals, which I […]
Those who have been self-shielding or on the NHS shielding list fear their support will vanish, leaving them at heightened risk for a second peak […]
Ann Robinson reviews the latest research from the top medical journals […]